CPHI Middle East 2026 Exhibition
CPHI Middle East 2026 is considered the leading event for the pharmaceutical and healthcare manufacturing industry across the Middle East and North Africa. Held in Riyadh, the exhibition brings together more than 1,000 companies including pharmaceutical manufacturers, API suppliers, pharmaceutical packaging companies, contract manufacturing organizations (CMO/CDMO), regulatory authorities, quality managers, physicians, and pharmacists.
The Importance of the Exhibition for the Saudi Pharmaceutical Sector
Saudi Arabia aims to increase local pharmaceutical manufacturing as part of Vision 2030 through localization initiatives led by the Saudi Food & Drug Authority (SFDA) and the “Made in Saudi” pharmaceutical programs. The exhibition provides Saudi manufacturers with access to the latest pharmaceutical production technologies, equipment, raw materials, and ready-to-execute joint manufacturing agreements with international companies.
Date & Venue
The exhibition will take place from December 14 to 16, 2026, at the Riyadh Exhibition & Convention Center in Malham. Spanning approximately 80,000 square meters, the event is expected to host visitors from more than 110 countries, creating an ideal environment for B2B meetings and major industry announcements.
Exhibited Sectors & Products
- Active Pharmaceutical Ingredients (APIs) and excipients
- Finished pharmaceutical products and chronic disease medications
- Pharmaceutical packaging and drug delivery solutions
- Pharmaceutical machinery, equipment, and production lines
- Biotechnology and vaccines
- Contract manufacturing services (CMO/CDMO)
- Pharmaceutical laboratories and quality assurance
- Regulatory affairs and drug registration services
Target Audience
The exhibition targets pharmaceutical factory managers, research and development professionals, quality assurance managers, regulatory affairs specialists, procurement managers, and executives from leading pharmaceutical companies such as SPIMACO, Tabuk Pharmaceuticals, Al Jazira Pharmaceuticals, and Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), in addition to representatives from the Ministry of Health, the Saudi Food & Drug Authority (SFDA), and the National Health Insurance Fund.
Scientific Conference & Associated Summits
The exhibition will be accompanied by an international scientific conference featuring experts from leading pharmaceutical companies, universities, and regulatory authorities. Sessions will discuss critical topics such as biologics development, generic medicines, orphan drugs, artificial intelligence in drug discovery, pharmaceutical regulations in Saudi Arabia and the GCC, and collaboration between academia and industry in pharmaceutical research.
The Exhibition’s Role in Vision 2030 & Pharmaceutical Localization
CPHI Middle East directly supports Saudi Arabia’s goal of increasing local pharmaceutical content to 40% by 2030, reducing pharmaceutical import dependency, and positioning the Kingdom as a regional hub for pharmaceutical manufacturing and exports. The exhibition also highlights partnership opportunities between Saudi and international companies for local licensed drug production, as well as investment opportunities in pharmaceutical industrial cities.
Register to Attend CPHI Middle East
Pre-registration is essential to gain professional access. The official exhibition website allows visitors to explore the full exhibitor list, schedule B2B meetings, and access conference sessions. Don’t miss the opportunity to attend the largest pharmaceutical industry gathering in the Middle East, hosted in Riyadh.